GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹7,157 Cr | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr |
What is the latest Profit & Loss Account Balance ratio of GLAND PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹7,157 Cr |
| Mar2024 | ₹6,788 Cr |
| Mar2023 | ₹6,015 Cr |
| Mar2022 | ₹5,234 Cr |
| Mar2021 | ₹4,023 Cr |
How is Profit & Loss Account Balance of GLAND PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,157 Cr | 5.44 | |
| Mar2024 | ₹6,788 Cr | 12.84 | |
| Mar2023 | ₹6,015 Cr | 14.92 | |
| Mar2022 | ₹5,234 Cr | 30.12 | |
| Mar2021 | ₹4,023 Cr | - | |
Compare Profit & Loss Account Balance of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹30,415.5 Cr | 9.7% | 10.8% | 15.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 9.7% |
10.8% |
15.6% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses